Professional Documents
Culture Documents
Contents
GLOBAL NEWS ................................................................................................................................... 1
CHINA LIKELY NOT TO SET NUMERICAL GDP GROWTH TARGET: GT POLL ............................................. 1
RBI MAY NEED TO AGGRESSIVELY CUT RATES ALONGSIDE FISCAL STIMULUS, SAY ECONOMISTS ......... 1
ASIAN STOCKS ADRIFT AS VACCINE RALLY FALTERS .............................................................................. 1
MACRO ECONOMY ........................................................................................................................... 1
NEEDED: STIMULUS PACKAGES WORTH 6PC OF GDP ........................................................................... 1
PANDEMIC WILL CHANGE THE AVIATION INDUSTRY FOREVER ............................................................. 2
BANGLADESH EYES FDI BOOM IN THE POST-PANDEMIC ERA ............................................................... 2
PERHAPS A ROLLING BUDGET CAN GIVE MORE LEEWAY TO FIGHT PANDEMIC .................................... 2
GOVT FOCUSES ON INCENTIVE PLAN TO ATTRACT RELOCATING BUSINESSES ....................................... 2
VIRUS THROWS 22.9PC INTO POVERTY: SURVEY .................................................................................. 3
CALL RATE STABLE BEFORE EID AMID BB'S SUPPORT ........................................................................... 3
CHINA-BACKED AIIB APPROVES $250 MILLION LOAN FOR BANGLADESH'S COVID-19 RESPONSE .......... 3
POWERFUL POLICYMAKERS HIGHLIGHT BARRIERS TO FDI .................................................................... 4
GOVT TO PROVIDE CAPITAL SUPPORT FOR JOBLESS EXPATS ................................................................ 4
BANGLADESH LOOKS TO LURE COMPANIES LEAVING CHINA ................................................................ 4
BANK..................................................................................................................................................... 4
MERCANTILE BANK TO START ISLAMIC BANKING OPERATIONS SOON .................................................. 4
FINANCIAL INSTITUTIONS ............................................................................................................. 4
NBFIS’ BORROWERS MISS OUT ON INTEREST PAYMENT SUSPENSION .................................................. 4
FOOD & ALLIED ................................................................................................................................. 5
INDUSTRIES MINISTRY AGAINST TOBACCO BAN DURING PANDEMIC ................................................... 5
PHARMACEUTICALS & CHEMICALS ........................................................................................... 5
MARICO’S PRODUCT DIVERSIFICATION MARCH CONTINUES ................................................................ 5
CAPITAL MARKET ............................................................................................................................ 5
BSEC GETS TWO NEW COMMISSIONERS .............................................................................................. 5
IPO SUBSCRIPTION OF EXPRESS INSURANCE DELAYED FURTHER .......................................................... 5
GLOBAL NEWS
RBI MAY NEED TO AGGRESSIVELY CUT RATES ALONGSIDE FISCAL STIMULUS, SAY ECONOMISTS
The Indian government’s frugal economic stimulus package has put pressure on the Reserve
Bank of India (RBI) to intervene, as analysts and economists say measures announced so far are
unlikely to have any meaningful impact soon.
The Indian government’s 266 billion US dollar economic rescue package outlined last week rests
largely on boosting company credit for micro, small and medium enterprises (MSMEs), but it
had scant new public spending, tax breaks or cash support to revive demand, reports Reuters.
“The cumulative government measures will help partly ease the cash squeeze felt by MSMEs in
the immediate term to help them bide time, but not fully resolve the current demand shock in
the face of the coronavirus,” said DBS economist Radhika Rao. “With disinflation set to
dominate, the RBI and policy committee will have the headroom to assume a growth-supportive
stance.”
Source: https://thefinancialexpress.com.bd/economy/rbi-may-need-to-aggressively-cut-rates-alongside-fiscal-stimulus-say-
economists-1589969748
MACRO ECONOMY
1
Due to the income shock emanating from the pandemic, 77.2 per cent of the vulnerable non-
poor fell below the poverty line, said the survey report styled "Livelihoods, Coping, and Support
during COVID-19 Crisis".
This would imply that beyond the 20.5 per cent of the population officially recognised as poor
there is a group of 'new poor' representing an additional 22.9 per cent of the population that
needed to be brought within the discussion on poverty.
Source: https://www.thedailystar.net/business/news/needed-stimulus-packages-worth-6pc-gdp-1904635
2
A taskforce will also be formed to deal with the incentive issues, especially in the
implementation stage, so that the investors do not feel offended when they come here
practically.
Briefing the media after the meeting, the commerce minister said that due to the adverse
impacts of coronavirus pandemic, many big companies would relocate their factories to those
countries where the cost of doing business was low.
Source: https://today.thefinancialexpress.com.bd/first-page/govt-focuses-on-incentive-plan-to-attract-relocating-businesses-
1589997491
CHINA-BACKED AIIB APPROVES $250 MILLION LOAN FOR BANGLADESH'S COVID-19 RESPONSE
Beijing-backed Asian Infrastructure Investment Bank (AIIB) said on Thursday it had approved a
$250 million loan to Bangladesh to help the country cope with the coronavirus pandemic.
The project, which will be cofinanced by the Asian Development Bank, is intended to help the
government with budget support to help the country's most vulnerable, according to a
statement. It is intended to strengthen social safety nets and mitigate the effects of job losses in
small and medium sized companies and the informal economy.
The loan is part of a $10 billion funding facility the AIIB has announced to help public and private
sector entities deal with the pandemic.
Source: https://tbsnews.net/economy/china-backed-aiib-approves-250-million-loan-bangladeshs-covid-19-response-83896
3
POWERFUL POLICYMAKERS HIGHLIGHT BARRIERS TO FDI
Three senior ministers and an adviser to the prime minister, on Wednesday, highlighted some
major bottlenecks they believe must be resolved for Bangladesh to attract a share of the
factories relocating from China.
They made the observations at a virtual meeting of an advisory committee to facilitate business
– with Commerce Minister Tipu Munshi in the chair.
Senior business leaders who attended the meeting echoed the government policymakers
regarding bringing foreign direct investment (FDI) into the country.
Source: https://tbsnews.net/economy/trade/powerful-policymakers-highlight-barriers-fdi-83827
BANK
FINANCIAL INSTITUTIONS
4
The Bangladesh Bank on May 3 brought great relief to borrowers when it ordered banks to
suspend interest on all loans for two months till May.
But the central bank did not extend this facility to NBFIs because they find that non-bank
lenders have to rely heavily on interest for their income as they have no other options like
commission, charges, and different type of fees that banks charge their customers.
Source: https://tbsnews.net/economy/banking/nbfis-borrowers-miss-out-interest-payment-suspension-83833
CAPITAL MARKET
5
The government has extended the ongoing shutdown until May 30 as the deadly virus goes
virulent.
The non-life insurer will raise a fund worth Tk 260.79 million from the capital market using the
fixed price method.
The initial public offering (IPO) subscription for shares of the company by the eligible investors
through electronic subscription system was supposed to begin on April 13 and close on April 20.
The company officials said IPO subscription has been suspended as the government extended
the general holiday until 30 May.
Source: https://today.thefinancialexpress.com.bd/stock-corporate/ipo-subscription-of-express-insurance-delayed-further-
1589989595
6
CONTACT US
Pakistan, Bangladesh & Sri Lanka Research
Anshuman Ray, MBA Founder, Chairman & CEO USA aray@1857advisors.net +12019209252
Rhoyce Sommerhaug, CFA Sr. Advisor, Top Down & Thematic Research USA rhoyce@1857advisors.net +14152267757
Dr. Ashish Chandra Ray, MS Sr. Advisor, Indian Specialty Pharmaceuticals IND dracray@1857advisors.net +917044067726
Dr. Krishna Ray, MD Sr. Advisor, Medical Diagnostics IND drkray@1857advisors.net +917044067726
Neelanjana Sarker, RIA, CPA, Finra S7/63 Forensic &Accounting Research USA investments@1857advisors.net +12019209252
Bijay Das, ACA Forensic &Accounting Research IND bijay@1857advisors.net +911146688777
Shafiqud Doulah, MBA Bangladesh Market Research BD shafiq@1857advisors.net +88029574328
Suranga Pradeep, ACA Forensic &Accounting Research SL suranga@1857advisors.net +94112505516
Surjeet Singh Web Delivery & Bloomberg IND itsupport@1857advisors.net +919350078193
Sanjaya Udara IT & Database SL itsupport@1857advisors.net +94112505516
Kanika Sharma Corporate Finance IND legal @1857advisors.net +919999033418
Offices
The information and opinions presented in this research report (“Report”) have been procured or derived by 1857 Advisors FZC (herein after referred to as “1857”) from sources
believed to be reliable, but 1857 makes no representation as to their accuracy, completeness or timeliness and does not assume any liability or responsibility for any loss
arise to any person or entity in connection with the use of the material presented in this report. The information is provided merely as a complementary service and do not
constitute an offer, solicitation for the purchase or sale of any financial instruments, inducement, promise, guarantee, warranty, or as an official confirmation of any
transactions or contract of any kind.
1857 may have issued at any time in the past, and may at any time in the future that are inconsistent with, and reach different conclusions from, the information presented in
this report and is under no obligation to ensure that such other communications are brought to the attention of any recipient of this report.
Prospective investors and others are cautioned that any forward-looking statements are not indication or guarantee of future performance and no representation or warranty,
express or implied, is made regarding future performance. The information, estimates and opinions in this report reflect a judgment at the time of publication by 1857 and are
subject to change without notice. While we endeavor to update on a reasonable basis the information discussed in the reports, there may be regulatory, compliance, internal
procedures within Sepoy Advisors or other reasons that prevent us from doing so.
The reports do not take into account the particular investment objectives, financial situations, risk profile or needs of individual clients. The user assumes the entire risk of any
use made of this information. Each recipient of the reports should make such investigation as deemed necessary to arrive at an independent evaluation of an investment in
the securities of companies referred to in such reports.
The reports are not for public distribution. Reproduction or dissemination, directly or indirectly, of research data and reports in whole or in part, is prohibited except with the
written permission of 1857. Persons into whose possession the reports may come are required to observe these restrictions.
1857and/or its Affiliates and its officers, directors and employees including the analysts/authors shall not be in any way responsible for any indirect, special, consequential,
punitive or exemplary damages including lost profits that may arise to any person from any inadvertent error in the information contained in the reports nor do they take
guarantee or assume liability for any omissions of the information contained therein. Information contained therein cannot be the basis for any claim, demand or cause of
action. These data, reports and information do not constitute scientific publication and do not carry any evidentiary value whatsoever.
www.1857advisors.net